Pharmaceutical Biotechnology Experts are professionals who apply advanced biological and biotechnological methods to develop new drugs and therapies. They focus on the use of living organisms, cells, and biological processes to create biologics such as monoclonal antibodies, therapeutic proteins, and vaccines. By harnessing the power of biotechnology, these experts are pioneering new treatments for complex diseases like cancer, diabetes, and genetic disorders. Their work plays a pivotal role in developing biologic therapies that offer personalized and targeted treatment options, improving the effectiveness and safety of healthcare. With the integration of cutting-edge technologies, these experts are at the forefront of developing next-generation treatments that can significantly alter disease progression.
These are work at the intersection of biology, chemistry, and pharmacology, using tools such as genetic engineering, cell culture, and gene editing techniques like CRISPR. Their primary goal is to optimize the production of high-quality biologic drugs while ensuring they are safe, scalable, and cost-effective for widespread use. Pharmaceutical biotechnology experts also navigate the complexities of regulatory approval processes, ensuring that new therapies meet the necessary standards for patient safety and efficacy. With the rise of biologic drugs in modern medicine, these professionals are critical in driving the innovation that addresses unmet medical needs and helps transform the future of healthcare.
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through design-inspired biotech- & biopharma-driven applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Genetic keys and nano locks: Unlocking personalized medicine
Srividya Narayanan, Northeastern University, United States
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico